New Oral Agents for Multiple Sclerosis, Including Novartis ...
PR Newswire (press release) - New York,NY,USA
For safety concerns, Tysabri was pulled from shelves in 2005 -- following a safety review, the drug was re-approved by the Food and Drug Administration in ...
See all stories on this topic